Sixth serological survey by Delhi govt reveals 97% of individuals has COVID-19 antibodies
Those under the age of 18 had a seropositivity rate of 88 per cent, while those above 18 had a seropositivity rate of 97 to 98 per cent.
The sixth serological survey performed by the Delhi government in September revealed that 97% of individuals tested had produced antibodies against the COVID-19 virus, said Health Minister Satyendar Jain on Thursday. He stated at a news conference that women had a greater seropositivity rate than males. Those under the age of 18 had a seropositivity rate of 88 per cent, while those above 18 had a seropositivity rate of 97 to 98 per cent. He went on to say that all districts had a seroprevalence rate of greater than 95%.
According to the Delhi health minister, individuals who had been immunised had a seropositivity rate of more than 97%, while those who had not been immunised had a seropositivity rate of 90%. "This was the biggest serosurvey ever conducted, with 28,000 samples gathered," he stated. The first survey was conducted after the deadly second wave of the COVID-19 epidemic hit Delhi in April and May. In January, the fifth round of sero survey revealed that 56.13 per cent of Delhi residents had produced antibodies against COVID-19.
Also Read |Â Delhi: Students to be back to schools from November 1, check all details here
According to the Delhi Health Bulletin, thirty-eight new COVID-19 cases were registered in the national capital on Wednesday, but no deaths were reported for the fifth day in a row.
With additional infections, Delhi's overall COVID tally has risen to 14,39,709, with 348 current cases. So far, the virus has claimed the lives of 25,091 individuals in the nation's capital.
In the national capital, the case fatality rate is 1.74 per cent. The percentage of positive is 0.06 per cent. With 13 additional people retrieved in the previous 24 hours, the city's total number of recoveries has risen to 14,14,270.
Also Read |Â When will children be vaccinated? India to soon issue guidelines on COVID vaccination for children
Â
Â